Endotoxemia clinical trials at University of California Health

1 research study open to eligible people

Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
open to eligible people ages 18 years and up
Prospective, multicenter, randomized, open-label study of standard of care plus the PMX cartridge versus standard of care alone in patients with endotoxemic septic shock
at UCLA UCSF

Our lead scientists for Endotoxemia research studies include David W. Boldt, MD.

Last updated: February 11, 2025

Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study